Testing for ALDH2 deficiency ranges from a simple adhesive patch soaked in ethanol, applied to your inner arm for about 15 minutes, to a laboratory genetic test that reads your DNA from a saliva sample or cheek swab. The patch test is cheap and fast but imperfect; the genetic test is definitive. Roughly 540 million people worldwide carry the ALDH2*2 variant responsible for the condition, most of them of East Asian descent, and knowing your status has implications well beyond whether alcohol makes you flush.1PubMed Central. The Alcohol Flush Response
What ALDH2 Deficiency Actually Is
When you drink alcohol, your body breaks it down in two main steps. First, alcohol dehydrogenase converts ethanol into acetaldehyde, a toxic compound. Then aldehyde dehydrogenase 2 (ALDH2) clears that acetaldehyde by converting it into harmless acetate. If your ALDH2 enzyme doesn’t work properly, acetaldehyde builds up in your blood and tissues, causing the well-known flush reaction: facial redness, rapid heartbeat, nausea, and warmth.2Europe PMC / PMC Central. Overview: how is alcohol metabolized by the body?
The deficiency stems from a single-letter change in the ALDH2 gene at a position called Glu504Lys (sometimes written as rs671). This variant, known as ALDH2*2, produces an enzyme with dramatically reduced activity. The mutation exerts what researchers call a dominant-negative effect, meaning even one copy of the variant drags down overall ALDH2 protein levels, not just the output of the affected copy.3Cancer Management and Research. Genetic variants of ALDH2-rs671 and CYP2E1-rs2031920 contributed to risk of hepatocellular carcinoma susceptibility in a Chinese population People who carry one copy (heterozygotes) still have some working enzyme, though their blood acetaldehyde levels after drinking are significantly higher than those without the variant, along with more pronounced cardiovascular effects and subjective discomfort.4Pharmacogenetics and Genomics. Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2 *2 gene allele People who carry two copies (homozygotes) have almost no functional ALDH2 at all and typically find even small amounts of alcohol intolerable.
The Ethanol Patch Test
The simplest and most accessible screening method is the ethanol patch test. A small gauze pad soaked in ethanol (usually 70% alcohol, the kind found in rubbing alcohol or medical prep pads) is taped to the inside of your upper arm for about 15 minutes. After you remove it, the skin underneath is checked for redness. A visible flush at the application site suggests your body cannot clear acetaldehyde efficiently, pointing toward ALDH2 deficiency.
The test has been in use since the late 1980s, when a study of 311 healthy Japanese adults and children showed it was a good indicator of ALDH2 status when compared against direct enzyme analysis from hair root samples.5PubMed. Ethanol patch test–a simple and sensitive method for identifying ALDH phenotype It works as a kind of miniature flush reaction: the ethanol penetrates the skin, gets converted locally to acetaldehyde, and if your local ALDH2 is deficient, the acetaldehyde causes visible dilation of blood vessels right at the site.
The appeal is obvious. It costs almost nothing, requires no lab equipment, and gives a result in minutes. You can do a rough version at home with a standard alcohol prep pad and medical tape. But there are real limits to what it can tell you.
How Accurate Is the Patch Test?
The patch test is better at ruling people in than ruling them out, and its accuracy depends on whether the redness is judged by eye or by more sophisticated methods. One study evaluating the test against genetic analysis reported sensitivity of about 82% and specificity around 97% when a clinician visually inspected the skin for color change. When the researchers added digital image analysis using a color model to quantify the redness, sensitivity improved to about 86% while specificity stayed the same.6PubMed. Alcohol patch test with hue-saturation-value model analysis predicts ALDH2 genetic polymorphism
That 82-86% sensitivity means roughly one in five or six people who actually carry the ALDH2*2 variant will get a negative result on the patch test. This is a meaningful miss rate. A separate comparison study found the patch test’s sensitivity and specificity at about 72% and 71%, respectively, which was notably lower than a simple flushing questionnaire that achieved sensitivity of 96% and specificity of 79%.7PubMed. Reliability of a flushing questionnaire and the ethanol patch test in screening for inactive aldehyde dehydrogenase-2 and alcohol-related cancer risk The questionnaire simply asked whether someone currently or formerly flushed after drinking, or sometimes flushed. That such a basic set of questions outperformed the patch test underscores that the patch is a rough screen, not a diagnosis.
There’s another quirk worth knowing. In a study of people with alcohol-induced asthma, among 68 subjects who tested positive on the ethanol patch, about 6% were actually genetically normal (homozygous for the typical allele), meaning the patch gave a false positive. And the test could not reliably distinguish heterozygotes from homozygotes.8PubMed Central. Screening for acetaldehyde dehydrogenase 2 genotype in alcohol-induced asthma by using the ethanol patch test A Japanese study comparing genotyping to the patch test similarly concluded that genetic analysis is essential for detecting alcohol sensitivity, because the patch test has inherent limitations, particularly with homozygous individuals who paradoxically sometimes test negative.9J-STAGE / The Tohoku Journal of Experimental Medicine. Analysis of Aldehyde Dehydrogenase 2 Gene Polymorphism and Ethanol Patch Test as a Screening Method for Alcohol Sensitivity
So the patch test is useful as a first-pass screen, especially in group settings like health fairs or school-based alcohol education programs where genetic testing isn’t practical. But if you want to know your actual genotype, you need a DNA-based test.
Genetic Testing for ALDH2 Status
The gold standard for identifying ALDH2 deficiency is genotyping the rs671 variant directly from your DNA. Several laboratory techniques exist for this, and they all essentially do the same thing: read the specific spot in your ALDH2 gene where the Glu504Lys change occurs and report whether you carry zero, one, or two copies of the variant.
The most common clinical method is a technique called TaqMan genotyping, which uses fluorescently labeled probes to distinguish the normal allele from the variant. A comparison of four different genotyping technologies for ALDH2 found all of them reliable, but TaqMan-based assays are widely used in research and clinical labs because they are fast, scalable, and well validated.10PubMed Central. Genotyping on ALDH2: Comparison of Four Different Technologies For you as the person getting tested, the technical details behind the scenes don’t matter much. What matters is that the result tells you definitively whether you are a normal homozygote (two working copies), a heterozygote (one working copy, one variant), or a variant homozygote (two deficient copies).
The sample you provide is typically a cheek swab or saliva collection. Some newer rapid-testing platforms have shown they can use whole blood, dried blood spots, buccal swabs, or saliva interchangeably, with results available in about 30 minutes and accuracy matching full laboratory sequencing.11PubMed Central. A direct isothermal amplification system adapted for rapid SNP genotyping of multifarious sample types Another system demonstrated successful genotyping of the ALDH2 variant from buccal swab and saliva samples using a portable magnetic lateral flow assay that doesn’t require expensive lab equipment.12iScience. Genotyping of Multiple Clinical Samples with a Combined Direct PCR and Magnetic Lateral Flow Assay These point-of-care platforms are pushing ALDH2 genotyping closer to something that could happen at a clinic visit rather than requiring a send-out lab test.
Several direct-to-consumer genetic testing services now include ALDH2 rs671 in their reports. If you’ve already done a consumer DNA test through one of the major companies, you may be able to look up your rs671 status in your raw data or through a third-party interpretation tool. The accuracy of consumer genotyping chips for a single well-characterized variant like rs671 is generally high, though clinical-grade confirmation is advisable if you plan to make medical decisions based on the result.
The Hair Follicle Assay
Before genetic testing became cheap and fast, researchers needed other ways to determine ALDH2 status. One creative approach was to measure enzyme activity directly in hair root cells. Hair follicles contain enough ALDH enzyme to allow analysis through isoelectric focusing or liquid chromatography techniques. A study using hair roots from both Caucasian and Japanese subjects found that people who flushed after drinking consistently showed absent or very low activity of the specific ALDH form, and that a ratio derived from enzyme activity at two different substrate concentrations gave a clean separation between deficient and normal individuals.13PubMed. Application of a high performance liquid chromatography method for screening of aldehyde dehydrogenase isozyme deficiency in hair roots from different ethnic groups
A study of Saskatchewan Cree Indians used all three methods (flushing questionnaire, ethanol patch test, and hair root enzyme analysis) and found they were in good agreement with each other.14Human Heredity. Absence of the Atypical Mitochondrial Aldehyde Dehydrogenase (ALDH2) Isozyme in Saskatchewan Cree Indians The hair root assay is rarely used today outside of specialized research, since a DNA test is simpler and gives you the actual genotype rather than an indirect measure of enzyme function. But it’s worth knowing about if you encounter older literature that describes ALDH2 “phenotyping” versus “genotyping.” The phenotyping methods measured what the enzyme does; the genotyping methods read what the gene says. They usually agree, but not always, because other genetic and environmental factors can modulate enzyme activity.
Why Knowing Your ALDH2 Status Matters Beyond the Flush
The flushing reaction itself is unpleasant but not dangerous. The real medical significance of ALDH2 deficiency lies elsewhere: in what happens when people with the variant drink anyway.
Acetaldehyde is classified as a carcinogen, and the organs it contacts most directly during and after drinking are in the upper digestive tract. A meta-analysis found that heterozygotes who drink had more than three times the risk of esophageal cancer compared to people with fully functional ALDH2 (the odds ratio was 3.19). Homozygotes, who almost universally avoid alcohol because it makes them so sick, actually had a lower risk (odds ratio 0.36) since their intolerance effectively protected them from exposure.15PubMed. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach This pattern has been confirmed in other populations. A South Korean case-control study found a similarly elevated risk in heterozygous men (odds ratio 2.75), with the association modified by alcohol consumption.16PubMed Central. Association between ALDH2 polymorphism and esophageal cancer risk in South Koreans: a case-control study
The takeaway is that heterozygotes are the group at highest risk, precisely because they can tolerate enough alcohol to keep drinking while accumulating acetaldehyde damage. Homozygotes are protected by their own misery. This makes testing especially important for people who flush mildly but continue to drink regularly. If you’re a heterozygote who has habituated to the flush, your acetaldehyde exposure is high, and the cancer risk data suggests that knowledge should shape your drinking decisions.
Acetaldehyde exposure also comes from sources beyond alcohol itself. Fermented foods, certain beverages, and tobacco smoke all contribute acetaldehyde to the upper digestive tract, acting as a cumulative carcinogen.17PubMed. Acetaldehyde as a common denominator and cumulative carcinogen in digestive tract cancers For people with ALDH2 deficiency, the impaired clearance of acetaldehyde from any source compounds the exposure.
ALDH2 Deficiency and Nitroglycerin Response
One of the more surprising connections involves the cardiac drug nitroglycerin, commonly prescribed for angina. ALDH2 plays a role in converting nitroglycerin into nitric oxide, the molecule that actually relaxes blood vessels and relieves chest pain. Laboratory studies have demonstrated that ALDH2 catalyzes the formation of nitric oxide from nitroglycerin, and this reaction is directly relevant to the drug’s mechanism of action.18Journal of Biological Chemistry. Aldh2-catalyzed Nitric Oxide Formation Is Sufficient for Nitroglycerin Bioactivation in Vascular Smooth Muscle Cells
Whether this translates into a meaningful clinical difference is still debated. One study directly measuring blood vessel dilation in Japanese subjects across all ALDH2 genotypes found no apparent difference in nitroglycerin-mediated vasodilation, suggesting that other pathways can compensate when ALDH2 is impaired.19PubMed. Vasodilatory effect of nitroglycerin in Japanese subjects with different aldehyde dehydrogenase 2 (ALDH2) genotypes The question isn’t fully settled, and some cardiologists still consider ALDH2 status a factor worth knowing when prescribing nitroglycerin, especially at high doses or for chronic use. For now, it’s an area where knowing your genotype might inform a conversation with your doctor, even if it won’t necessarily change your prescription.
Links to Alzheimer’s Disease
Beyond cancer and drug metabolism, ALDH2 deficiency has been linked to neurodegeneration. Recent meta-analyses support a relationship between the ALDH2*2 variant and Alzheimer’s disease. Mouse models that lack ALDH2 or overexpress the human ALDH2*2 variant develop Alzheimer’s-like brain pathology.20PubMed Central. Impact of common ALDH2 inactivating mutation and alcohol consumption on Alzheimer’s disease
The mechanism appears to involve not just acetaldehyde from alcohol but also endogenous aldehydes, reactive molecules that your cells produce naturally during oxidative stress. When ALDH2 doesn’t clear these aldehydes efficiently, they accumulate and trigger inflammation and mitochondrial dysfunction. Studies of skin cells from Alzheimer’s patients carrying the ALDH2*2 mutation showed increased aldehydic load, oxidative stress, and mitochondrial problems compared to healthy controls, and ethanol exposure worsened these effects.21PubMed Central. Aldehyde dehydrogenase 2 activity and aldehydic load contribute to neuroinflammation and Alzheimer’s disease related pathology The implication is that ALDH2 deficiency may be a chronic low-level risk factor for neurodegeneration independent of alcohol consumption, though alcohol makes it worse.
Experimental Treatments Targeting ALDH2
If you can’t fix the gene, can you fix the enzyme? Researchers have been working on small-molecule activators that boost ALDH2 activity even in people carrying the variant. The best-studied compound is called Alda-1, which binds to the ALDH2 enzyme and stabilizes it in a more active configuration. In mouse models carrying one copy of the human ALDH2*2 variant, Alda-1 combined with another activator called Alda-89 reduced acetaldehyde-induced behavioral impairment by rapidly lowering blood ethanol and acetaldehyde levels.22PubMed Central. Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo
Perhaps more exciting from a cancer-prevention standpoint, Alda-1 treatment significantly reduced alcohol-derived DNA damage in the esophagus of mice carrying the human ALDH2*2 mutation, even when those mice were drinking more alcohol.23Carcinogenesis. Protective effects of Alda-1, an ALDH2 activator, on alcohol-derived DNA damage in the esophagus of human ALDH2*2 (Glu504Lys) knock-in mice Alda-1 has also been reported to protect against liver damage and central nervous system alterations caused by acetaldehyde exposure.24PubMed. Pharmacological activators of ALDH2: A new strategy for the treatment of alcohol use disorders
These are still animal and cell studies. No ALDH2 activator is approved for human use yet. But the research suggests that in the future, people who know they carry the ALDH2*2 variant might have pharmaceutical options to reduce their risk, making genotype knowledge even more valuable.
The Evolutionary Backstory of ALDH2*2
It might seem strange that a variant causing such clear health problems persists in hundreds of millions of people. One hypothesis links the variant’s prevalence to the history of rice cultivation in East and Southeast Asia. A study analyzing genetic and agricultural data across Chinese counties found a statistically significant association between the historical extent of rice paddy farming in a region and the frequency of the ALDH2 rs671 variant there, after controlling for a wide range of potential confounders.25PubMed Central. Relationship between rice farming and polygenic scores potentially linked to agriculture in China The proposed explanation is that rice fermentation led to early and widespread alcohol production, and the ALDH2*2 variant may have conferred a selective advantage in that environment, perhaps by discouraging heavy drinking in a society where alcohol was readily available. Whether that advantage outweighed the health costs is still debated, but the geographic overlap between rice-farming history and ALDH2*2 prevalence is striking.
This history also explains why ALDH2 deficiency testing is overwhelmingly discussed in the context of East Asian populations. The variant is rare to absent in people of European, African, and most other ancestries. If you are of East Asian, Southeast Asian, or mixed ancestry with roots in those regions, testing is most likely to be informative. But the variant does occasionally appear in other populations, so ancestry alone is not a guarantee.
Choosing the Right Test for Your Situation
If you just want a quick sense of whether you might carry the variant, the flushing questionnaire is actually the easiest starting point. Ask yourself whether you reliably turn red after even a small amount of alcohol, or whether you used to flush when you first started drinking. If the answer to either is yes, the probability is high. The patch test adds a layer of objective evidence and can be useful for people who don’t drink or who started drinking young enough that they can’t remember their early reactions.
If you want a definitive answer, particularly if you’re making medical decisions about alcohol consumption, cancer screening frequency, or medication choices, get the genetic test. It can be ordered through a doctor, through some pharmacogenomic testing services, or accessed via consumer genomics platforms. The saliva or cheek-swab collection is painless, and results typically come back within a few weeks from clinical labs. Newer rapid platforms could bring that down to the same day in a clinic setting.
The hair follicle enzyme assay is essentially a historical curiosity at this point. It was valuable when DNA testing was expensive and slow, but it has been superseded for all practical purposes. You’re unlikely to encounter it outside of research papers from the 1980s and 1990s.
Whatever method you use, the most important thing is what you do with the information. For heterozygotes who drink, knowing the genotype is a concrete, personalized risk factor that maps directly onto decisions about how much alcohol to consume and how aggressively to screen for upper digestive tract cancers. That kind of actionable genetic information is still relatively rare in medicine, which is part of what makes ALDH2 status unusually worth knowing.